Sorafenib and Dacarbazine in Soft Tissue Sarcoma

Clinical trial NCT00837148 · COMPLETED

Trial details

NCT number: NCT00837148
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sarcoma Synovial Sarcoma Leiomyosarcoma Malignant Peripheral Nerve Sheath Tumor

Start date: 2009-02-01
Primary completion: 2013-11-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.